Danaher to acquire abcam

Washington , aug. 28, 2023 /prnewswire/ -- danaher corporation (nyse: dhr) ("danaher" or the "company"), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire abcam plc (nasdaq: abcm), a leading global supplier of protein consumables, pursuant to which danaher will acquire all of the outstanding shares of abcam for $24.00 per share in cash, or a total enterprise value of approximately $5.7 billion including assumed indebtedness and net of acquired cash. founded in 1998 and headquartered in cambridge, uk, abcam offers the scientific community highly validated antibodies, reagents, biomarkers and assays to address targets in biological pathways that are critical for advancing drug discovery, life sciences research, and diagnostics.
ABCM Ratings Summary
ABCM Quant Ranking